|
|
| Melanoma - Targeted Therapeutics |
|
| Published : 2007/07 |
| The risk of malignant melanoma has more than doubled in the past decade. The incidence of melanoma is rising faster than that of any other cancer. ... |
| OTC Distribution in Europe: 2007 Edition Exploring New Frontiers |
|
| Published : 2007/07 |
| This expanded 2007 edition of OTC Distribution in Europe is the largest and most up-to-date strategic analysis of the channel networks influencing consumer access to non-prescription medicines and OTC self-medication and self-care in Europefs main market ... |
| PharmaVitae Generics - Teva |
|
| Published : 2007/07 |
| This analysis examines the historical and forecast performance for Teva in the generic pharmaceutical sector. ... |
| Pipeline and Commercial Insight: Pediatric and Adolescent Vaccines |
|
| Published : 2007/07 |
| The pediatric and adolescent vaccines market encompasses many different classes. DTP and MMR combinations continue to form the mainstay of childhood immunization; however, their growth potential is limited. The key opportunities lie in novel, innovative a ... |
| The Global HIV/AIDS Market Outlook to 2012 |
|
| Published : 2007/07 |
| The Global HIV/AIDS Market Outlook to 2012' is a new management report published by Business Insights that provides comprehensive coverage of the global HIV/AIDS market, incorporating a detailed epidemiological analysis of the prevalence of HIV/AIDS and k ... |
| The Pharmaceutical Market: Ukraine |
|
| Published : 2007/07 |
| Ukraine represents a potentially major and lucrative pharmaceutical market. In practice, this is not the case. Most domestic manufacturers are very small and focus on the production of older drugs. This report is ideal for executives wanting to understand ... |
| The Pharmaceutical Market: USA |
|
| Published : 2007/07 |
| This report is ideal for executives wanting to understand the key drivers in the pharmaceutical market and have access to a wealth of statistical data, including five-year market projections. ... |
| WORLD PHARMACEUTICAL PACKAGING to 2011 |
|
| Published : 2007/07 |
| World pharmaceutical packaging demand is forecast to rise 5.9 percent annually to over $34 billion in 2011. Western Europe, the US and Japan will absorb nearly three-fourths of this amount due to the presence of the most advanced drugproducing sectors. ... |
| Advances in Sleep Pharmaceuticals |
|
| Published : 2007/06 |
| This Frost & Sullivan research service titled Advances in Sleep Pharmaceuticals provides an overview of the ongoing developments in this sector and covers the associated drivers and challenges in great detail. ... |
| Antibody Drug Target Atlas in Oncology |
|
| Published : 2007/06 |
| The elaborate advances towards the blueprinting of the altered molecular networks that lie behind cancer development have paved the way for targeted therapy in cancer. ... |
| Arthritis - US - June 2007 |
|
| Published : 2007/06 |
| This report covers the prevalence, incidence, costs, causes, prevention, and treatments of arthritis. Comprised of more than 100 distinct conditions, Arthritis affects approximately 50 million Americans. ... |
| Blockbuster Patent Expirations and the Future of the Generics Market |
|
| Published : 2007/06 |
| Approximately 90 pharmaceuticals achieved blockbuster status in 2006, generating more than $200 billion in sales-approximately 30% of the global pharmaceutical market. However, in 2007, eight blockbuster brands- with combined 2006 sales of $13 billion in ... |
| Brands & Strategies: Psoriasis |
|
| Published : 2007/06 |
| Biologic therapies have had a major impact on the psoriasis market since the first such agent was approved by the FDA in 2003. In the moderate-to-severe psoriasis market, biologic agents alone totaled over $900 million in 2006. ... |
| Brands & Strategies: UA/NSTEMI |
|
| Published : 2007/06 |
| In 2006, the unstable angina/non-ST-elevation myocardial infarction (UA/NSTEMI) market, valued at more than $820 million in the United States, Europe, and Japan, was dominated by a handful of premium-priced therapies, including Schering-Plough' s gpIIb/II ... |
| CNS Market Trends, 2007 to 2010 |
|
| Published : 2007/06 |
| The global market for drugs treating Central Nervous System (CNS) disorders has grown rapidly in recent years to reach US$55.5 billion in 2005, a year-on-year increase of 6.6%. ... |
| eCommerce Strategies for the Life Science Market |
|
| Published : 2007/06 |
| Life science suppliers were among the first companies in any industry to grasp the commercial potential of the Web, and some leading companies are now receiving more than 50% of their orders online. However, launching an electronic catalog and shopping ca ... |
| European Animal Health Regulations |
|
| Published : 2007/06 |
| This report, which has two volumes, is aimed at anyone who needs to understand the basics of the regulations. It provides information on how to plan for the acquisition of a veterinary pharmaceutical product approval in the region in question. ... |
| European Osteoarthritis Markets |
|
| Published : 2007/06 |
| This Frost & Sullivan research service titled European Osteoarthritis Market provides an overview of current treatment options along with a complete analysis of key market drivers, restraints and trends prevailing in the market. ... |
|
|
Top
View Cart